Mariagrazia Pizza: Difference between revisions
Duncan.Hull (talk | contribs) refs |
Duncan.Hull (talk | contribs) No longer an orphan |
||
Line 1: | Line 1: | ||
{{Short description|Vaccine researcher and academic}} |
{{Short description|Vaccine researcher and academic}} |
||
{{Orphan|date=June 2023}} |
|||
{{Infobox scientist |
{{Infobox scientist |
||
| name = Mariagrazia Pizza |
| name = Mariagrazia Pizza |
||
Line 10: | Line 9: | ||
| alma_mater = [[University of Naples Federico II]] |
| alma_mater = [[University of Naples Federico II]] |
||
}} |
}} |
||
'''Mariagrazia Pizza''' {{post-nominals|country=GBR|MAE}} is an Italian vaccine researcher who is a professor at [[Imperial College London]].<ref name=gs>{{Google scholar id}}</ref><ref name=epmc>{{EuropePMC}}</ref> She worked as Senior Scientific Director for Bacterial Vaccines at [[GSK plc]]. She was involved with the development of the first [[pertussis vaccine]]. In 2023, she was awarded the IVI-SK bioscience Park MahnHoon Award. |
'''Mariagrazia Pizza''' {{post-nominals|country=GBR|MAE}} is an Italian vaccine researcher who is a professor at [[Imperial College London]].<ref name=gs>{{Google scholar id}}</ref><ref name=epmc>{{EuropePMC}}</ref> She worked as Senior Scientific Director for Bacterial Vaccines at [[GSK plc]].<ref name="Pizza2000">{{cite journal|last1=Pizza|first1=M.|authorlink1=Mariagrazia Pizza|title=Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome Sequencing|journal=Science|volume=287|issue=5459|year=2000|pages=1816–1820|doi=10.1126/science.287.5459.1816|pmid=10710308|bibcode=2000Sci...287.1816.}}</ref><ref name="PizzaFontana1996">{{cite journal|last1=Pizza|first1=Mariagrazia|authorlink1=Mariagrazia Pizza|last2=Fontana|first2=Maria Rita|last3=Scarlato|first3=Vincenzo|last4=Rappuoli|first4=Rino|title=Genetic Detoxification of Bacterial Toxins|volume=4|year=1996|pages=91–110|doi=10.1385/0-89603-334-1:91|pmid=21359697|journal=Vaccine Protocols|isbn=0-89603-334-1}}</ref> She was involved with the development of the first [[pertussis vaccine]]. In 2023, she was awarded the IVI-SK bioscience Park MahnHoon Award.<ref name=linkedin>{{linkedin}}</ref> |
||
== Early life and education == |
== Early life and education == |
||
Line 16: | Line 15: | ||
== Research and career == |
== Research and career == |
||
Pizza has focused on the design and development of new vaccines. In 1986, she joined Sclavo, a vaccine research centre in [[Siena]]. She spent six years there, contributing to the development of the first [[pertussis vaccine]],<ref name=":0" /> which was able to protect infants, and was safer and more immuno-active than other pertussis vaccines on the market.<ref name=":0" /> Sclavo was sold to Chiron, which was eventually acquired by Novartis. Motivated by their success and advances in whole-genome sequencing, Pizza started working on a [[Meningococcal vaccine]].<ref name=":0" /><ref>{{Cite web |last=Galvani |first=Rotary |date=2021-02-01 |title=Dr.ssa Mariagrazia Pizza, vaccini in tempo di pandemia |url=https://www.rotarybolognagalvani.org/dr-ssa-mariagrazia-pizza-vaccini-in-tempo-di-pandemia/ |access-date=2023-06-15 |website=Rotary Bologna Galvani |language=it-IT}}</ref> She joined [[GSK plc]] in 2016.<ref name="Pizza 808–810"/> |
Pizza has focused on the design and development of new vaccines. In 1986, she joined Sclavo, a vaccine research centre in [[Siena]]. She spent six years there, contributing to the development of the first [[pertussis vaccine]],<ref name=":0" /> which was able to protect infants, and was safer and more immuno-active than other pertussis vaccines on the market.<ref name=":0" /> Sclavo was sold to Chiron, which was eventually acquired by Novartis. Motivated by their success and advances in [[whole-genome sequencing]], Pizza started working on a [[Meningococcal vaccine]].<ref name=":0" /><ref>{{Cite web |last=Galvani |first=Rotary |date=2021-02-01 |title=Dr.ssa Mariagrazia Pizza, vaccini in tempo di pandemia |url=https://www.rotarybolognagalvani.org/dr-ssa-mariagrazia-pizza-vaccini-in-tempo-di-pandemia/ |access-date=2023-06-15 |website=Rotary Bologna Galvani |language=it-IT}}</ref> She joined [[GSK plc]] in 2016.<ref name="Pizza 808–810"/> |
||
In 2023, Pizza joined the faculty at [[Imperial College London]].{{cn|date=June 2023}} |
In 2023, Pizza joined the faculty at [[Imperial College London]].{{cn|date=June 2023}} |
Revision as of 19:53, 21 June 2023
Mariagrazia Pizza | |
---|---|
Born | |
Alma mater | University of Naples Federico II |
Awards | EMBO Member (2000)[1] |
Scientific career | |
Fields | Vaccines Pathogenesis[2] |
Institutions | Imperial College London GSK plc European Molecular Biology Laboratory |
Mariagrazia Pizza MAE is an Italian vaccine researcher who is a professor at Imperial College London.[2][3] She worked as Senior Scientific Director for Bacterial Vaccines at GSK plc.[4][5] She was involved with the development of the first pertussis vaccine. In 2023, she was awarded the IVI-SK bioscience Park MahnHoon Award.[6]
Early life and education
Pizza was born in Eboli, Italy and lived there until 1980.[7] She studied chemistry and pharmaceutical science at the University of Naples Federico II.[8] Her dissertation used nuclear magnetic resonance to explore the structure of opioid peptides.[8] When a family member became ill, she decided to learn more about pharmaceutical design. She moved to the European Molecular Biology Laboratory in Heidelberg, where she learnt molecular biology and engineering.[8]
Research and career
Pizza has focused on the design and development of new vaccines. In 1986, she joined Sclavo, a vaccine research centre in Siena. She spent six years there, contributing to the development of the first pertussis vaccine,[8] which was able to protect infants, and was safer and more immuno-active than other pertussis vaccines on the market.[8] Sclavo was sold to Chiron, which was eventually acquired by Novartis. Motivated by their success and advances in whole-genome sequencing, Pizza started working on a Meningococcal vaccine.[8][9] She joined GSK plc in 2016.[7]
In 2023, Pizza joined the faculty at Imperial College London.[citation needed]
Awards and honours
- 2000 Elected a member of the European Molecular Biology Organization (EMBO)[1]
- 2018 Elected a Member of the Academia Europaea (MAE)[10]
- 2023 IVI-SK bioscience Park MahnHoon Award[11]
Selected publications
- M Pizza; Vincenzo Scarlato; V Masignani; et al. (1 March 2000). "Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing". Science. 287 (5459): 1816–1820. doi:10.1126/SCIENCE.287.5459.1816. ISSN 0036-8075. PMID 10710308. Wikidata Q33892877.
- H Tettelin; N J Saunders; J Heidelberg; et al. (1 March 2000). "Complete genome sequence of Neisseria meningitidis serogroup B strain MC58". Science. 287 (5459): 1809–1815. doi:10.1126/SCIENCE.287.5459.1809. ISSN 0036-8075. PMID 10710307. Wikidata Q22065549.
- Marzia M Giuliani; Jeannette Adu-Bobie; Maurizio Comanducci; et al. (6 July 2006). "A universal vaccine for serogroup B meningococcus". Proceedings of the National Academy of Sciences of the United States of America. 103 (29): 10834–10839. Bibcode:2006PNAS..10310834G. doi:10.1073/PNAS.0603940103. ISSN 0027-8424. PMC 2047628. PMID 16825336. Wikidata Q36101910.
Personal life
Pizza has two children.[8]
References
- ^ a b "Mariagrazia Pizza". people.embo.org. Retrieved 2023-06-15.
- ^ a b Mariagrazia Pizza publications indexed by Google Scholar
- ^ Mariagrazia Pizza publications from Europe PubMed Central
- ^ Pizza, M. (2000). "Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome Sequencing". Science. 287 (5459): 1816–1820. Bibcode:2000Sci...287.1816.. doi:10.1126/science.287.5459.1816. PMID 10710308.
- ^ Pizza, Mariagrazia; Fontana, Maria Rita; Scarlato, Vincenzo; Rappuoli, Rino (1996). "Genetic Detoxification of Bacterial Toxins". Vaccine Protocols. 4: 91–110. doi:10.1385/0-89603-334-1:91. ISBN 0-89603-334-1. PMID 21359697.
- ^ Mariagrazia Pizza on LinkedIn
- ^ a b Pizza, Mariagrazia (August 2011). "A life passion for vaccines". Human Vaccines. 7 (8): 808–810. doi:10.4161/hv.7.8.17637. ISSN 1554-8600.
- ^ a b c d e f g Pizza, Mariagrazia (2017-01-12). "Spotlight on… Mariagrazia Pizza". FEMS Microbiology Letters: fnw299. doi:10.1093/femsle/fnw299. ISSN 1574-6968. PMID 28087618.
- ^ Galvani, Rotary (2021-02-01). "Dr.ssa Mariagrazia Pizza, vaccini in tempo di pandemia". Rotary Bologna Galvani (in Italian). Retrieved 2023-06-15.
- ^ "Academy of Europe: Pizza Mariagrazia". ae-info.org. Retrieved 2023-06-15.
- ^ Em, Aerie (2023-03-09). "Profs. Andrew Pollard / Sarah Gilbert and Drs. Rino Rappuoli / Mariagrazia Pizza named winners of second IVI – SK bioscience Park MahnHoon Award". IVI. Retrieved 2023-06-14.
- Living people
- Vaccinologists
- 20th-century Italian women scientists
- 20th-century Italian scientists
- 21st-century Italian women scientists
- 21st-century Italian scientists
- People from Eboli
- GSK plc people
- University of Naples Federico II alumni
- Academics of Imperial College London
- Members of the European Molecular Biology Organization
- Members of Academia Europaea